Shriram Pistons & Rings Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: September 5, 2025, 5:19 pm

Quick Insight

Shriram Pistons & Rings Ltd, with a market capitalization of ₹11,312 Cr. and a share price of ₹2,568, presents an intriguing investment opportunity in the auto ancillary – engine parts sector. The company boasts a healthy P/E ratio of 21.6, indicating potential for growth, supported by a robust ROE of 23.2% and ROCE of 25.7%. With an OPM of 20% and a net profit of ₹516 Cr., Shriram Pistons & Rings demonstrates operational efficiency and profitability. Furthermore, the company's strong reserves of ₹2,350 Cr. and low borrowings of ₹508 Cr. underscore its financial stability. Investors may find value in the stock given its attractive P/BV of 3.47x and solid ICR of 24.33x, suggesting a sound financial position.

Competitors of Shriram Pistons & Rings Ltd

All Competitor Stocks of Shriram Pistons & Rings Ltd

Quarterly Result

Last Updated: August 20, 2025, 3:40 am

Below is a detailed analysis of the quarterly data for Shriram Pistons & Rings Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:

• For Sales, as of Jun 2025, the value is 963.00 Cr.. The value appears to be declining and may need further review. It has decreased from 988.00 Cr. (Mar 2025) to 963.00 Cr., marking a decrease of 25.00 Cr..
• For Expenses, as of Jun 2025, the value is 768.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 778.00 Cr. (Mar 2025) to 768.00 Cr., marking a decrease of 10.00 Cr..
• For Operating Profit, as of Jun 2025, the value is 195.00 Cr.. The value appears to be declining and may need further review. It has decreased from 210.00 Cr. (Mar 2025) to 195.00 Cr., marking a decrease of 15.00 Cr..
• For OPM %, as of Jun 2025, the value is 20.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Mar 2025) to 20.00%, marking a decrease of 1.00%.
• For Other Income, as of Jun 2025, the value is 28.00 Cr.. The value appears strong and on an upward trend. It has increased from 27.00 Cr. (Mar 2025) to 28.00 Cr., marking an increase of 1.00 Cr..
• For Interest, as of Jun 2025, the value is 9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Mar 2025) to 9.00 Cr., marking an increase of 1.00 Cr..
• For Depreciation, as of Jun 2025, the value is 32.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 28.00 Cr. (Mar 2025) to 32.00 Cr., marking an increase of 4.00 Cr..
• For Profit before tax, as of Jun 2025, the value is 183.00 Cr.. The value appears to be declining and may need further review. It has decreased from 201.00 Cr. (Mar 2025) to 183.00 Cr., marking a decrease of 18.00 Cr..
• For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Mar 2025) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Jun 2025, the value is 135.00 Cr.. The value appears to be declining and may need further review. It has decreased from 152.00 Cr. (Mar 2025) to 135.00 Cr., marking a decrease of 17.00 Cr..
• For EPS in Rs, as of Jun 2025, the value is 30.35. The value appears to be declining and may need further review. It has decreased from 33.26 (Mar 2025) to 30.35, marking a decrease of 2.91.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 5:16 am

Growth

Last Updated: September 5, 2025, 1:31 pm

Balance Sheet

Last Updated: July 25, 2025, 2:21 pm

Below is a detailed analysis of the balance sheet data for Shriram Pistons & Rings Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 44.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 44.00 Cr..
• For Reserves, as of Mar 2025, the value is 2,350.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,882.00 Cr. (Mar 2024) to 2,350.00 Cr., marking an increase of 468.00 Cr..
• For Borrowings, as of Mar 2025, the value is 508.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 487.00 Cr. (Mar 2024) to 508.00 Cr., marking an increase of 21.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 821.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 723.00 Cr. (Mar 2024) to 821.00 Cr., marking an increase of 98.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 3,723.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,136.00 Cr. (Mar 2024) to 3,723.00 Cr., marking an increase of 587.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 1,203.00 Cr.. The value appears strong and on an upward trend. It has increased from 934.00 Cr. (Mar 2024) to 1,203.00 Cr., marking an increase of 269.00 Cr..
• For CWIP, as of Mar 2025, the value is 58.00 Cr.. The value appears strong and on an upward trend. It has increased from 31.00 Cr. (Mar 2024) to 58.00 Cr., marking an increase of 27.00 Cr..
• For Investments, as of Mar 2025, the value is 36.00 Cr.. The value appears to be declining and may need further review. It has decreased from 115.00 Cr. (Mar 2024) to 36.00 Cr., marking a decrease of 79.00 Cr..
• For Other Assets, as of Mar 2025, the value is 2,425.00 Cr.. The value appears strong and on an upward trend. It has increased from 2,056.00 Cr. (Mar 2024) to 2,425.00 Cr., marking an increase of 369.00 Cr..
• For Total Assets, as of Mar 2025, the value is 3,723.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,136.00 Cr. (Mar 2024) to 3,723.00 Cr., marking an increase of 587.00 Cr..

Notably, the Reserves (2,350.00 Cr.) exceed the Borrowings (508.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Mutual Fund Holdings

Key Financial Ratios

After reviewing the key financial ratios for Shriram Pistons & Rings Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 115.02. This value is within the healthy range. It has increased from 100.47 (Mar 24) to 115.02, marking an increase of 14.55.
• For Diluted EPS (Rs.), as of Mar 25, the value is 115.02. This value is within the healthy range. It has increased from 100.47 (Mar 24) to 115.02, marking an increase of 14.55.
• For Cash EPS (Rs.), as of Mar 25, the value is 144.21. This value is within the healthy range. It has increased from 124.03 (Mar 24) to 144.21, marking an increase of 20.18.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 543.40. It has increased from 455.83 (Mar 24) to 543.40, marking an increase of 87.57.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 543.40. It has increased from 458.04 (Mar 24) to 543.40, marking an increase of 85.36.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 805.86. It has increased from 701.32 (Mar 24) to 805.86, marking an increase of 104.54.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 189.71. This value is within the healthy range. It has increased from 165.11 (Mar 24) to 189.71, marking an increase of 24.60.
• For PBIT / Share (Rs.), as of Mar 25, the value is 162.54. This value is within the healthy range. It has increased from 140.66 (Mar 24) to 162.54, marking an increase of 21.88.
• For PBT / Share (Rs.), as of Mar 25, the value is 154.75. This value is within the healthy range. It has increased from 133.74 (Mar 24) to 154.75, marking an increase of 21.01.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 117.04. This value is within the healthy range. It has increased from 99.58 (Mar 24) to 117.04, marking an increase of 17.46.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 115.02. This value is within the healthy range. It has increased from 100.47 (Mar 24) to 115.02, marking an increase of 14.55.
• For PBDIT Margin (%), as of Mar 25, the value is 23.54. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 23.54.
• For PBIT Margin (%), as of Mar 25, the value is 20.17. This value exceeds the healthy maximum of 20. It has increased from 20.05 (Mar 24) to 20.17, marking an increase of 0.12.
• For PBT Margin (%), as of Mar 25, the value is 19.20. This value is within the healthy range. It has increased from 19.06 (Mar 24) to 19.20, marking an increase of 0.14.
• For Net Profit Margin (%), as of Mar 25, the value is 14.52. This value exceeds the healthy maximum of 10. It has increased from 14.19 (Mar 24) to 14.52, marking an increase of 0.33.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.27. This value is within the healthy range. It has decreased from 14.32 (Mar 24) to 14.27, marking a decrease of 0.05.
• For Return on Networth / Equity (%), as of Mar 25, the value is 21.16. This value is within the healthy range. It has decreased from 23.13 (Mar 24) to 21.16, marking a decrease of 1.97.
• For Return on Capital Employeed (%), as of Mar 25, the value is 25.50. This value is within the healthy range. It has decreased from 26.55 (Mar 24) to 25.50, marking a decrease of 1.05.
• For Return On Assets (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has decreased from 14.10 (Mar 24) to 13.58, marking a decrease of 0.52.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.07. This value is below the healthy minimum of 0.2. It has decreased from 0.10 (Mar 24) to 0.07, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.19. This value is within the healthy range. It has decreased from 0.23 (Mar 24) to 0.19, marking a decrease of 0.04.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 1.03. It has decreased from 1.12 (Mar 24) to 1.03, marking a decrease of 0.09.
• For Current Ratio (X), as of Mar 25, the value is 2.48. This value is within the healthy range. It has increased from 2.43 (Mar 24) to 2.48, marking an increase of 0.05.
• For Quick Ratio (X), as of Mar 25, the value is 1.96. This value is within the healthy range. It has increased from 1.95 (Mar 24) to 1.96, marking an increase of 0.01.
• For Inventory Turnover Ratio (X), as of Mar 25, the value is 3.33. This value is below the healthy minimum of 4. It has increased from 3.20 (Mar 24) to 3.33, marking an increase of 0.13.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 7.46 (Mar 24) to 0.00, marking a decrease of 7.46.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 6.00 (Mar 24) to 0.00, marking a decrease of 6.00.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 92.54 (Mar 24) to 0.00, marking a decrease of 92.54.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 94.00 (Mar 24) to 0.00, marking a decrease of 94.00.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 24.33. This value is within the healthy range. It has increased from 23.88 (Mar 24) to 24.33, marking an increase of 0.45.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 16.01. This value is within the healthy range. It has increased from 15.40 (Mar 24) to 16.01, marking an increase of 0.61.
• For Enterprise Value (Cr.), as of Mar 25, the value is 7,845.82. It has decreased from 8,324.48 (Mar 24) to 7,845.82, marking a decrease of 478.66.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.21. This value is within the healthy range. It has decreased from 2.69 (Mar 24) to 2.21, marking a decrease of 0.48.
• For EV / EBITDA (X), as of Mar 25, the value is 9.39. This value is within the healthy range. It has decreased from 11.45 (Mar 24) to 9.39, marking a decrease of 2.06.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.34. This value is within the healthy range. It has decreased from 2.80 (Mar 24) to 2.34, marking a decrease of 0.46.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 92.53 (Mar 24) to 0.00, marking a decrease of 92.53.
• For Price / BV (X), as of Mar 25, the value is 3.47. This value exceeds the healthy maximum of 3. It has decreased from 4.51 (Mar 24) to 3.47, marking a decrease of 1.04.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.34. This value is within the healthy range. It has decreased from 2.80 (Mar 24) to 2.34, marking a decrease of 0.46.
• For EarningsYield, as of Mar 25, the value is 0.06. This value is below the healthy minimum of 5. It has increased from 0.05 (Mar 24) to 0.06, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness